Status Asthmaticus Subcutaneous  Agonists  Epinephrine/terbutaline  No advantage over inhaled  agonists  Increased side effects  Indications:  inability to cooperate with inhalation therapy  rapidly decompensating patient  failure to respond to inhaled beta-agonists
{}